Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2K Sell
553
-12
-2% -$256 ﹤0.01% 1864
2026
Q1
$11.4K Sell
565
-23
-4% -$511 ﹤0.01% 1803
2025
Q4
$11.3K Buy
588
+26
+5% +$547 ﹤0.01% 1832
2025
Q3
$13.5K Buy
562
+10
+2% +$234 ﹤0.01% 1780
2025
Q2
$10.7K Hold
552
﹤0.01% 1857
2025
Q1
$7.1K Buy
552
+2
+0.4% +$32 ﹤0.01% 2025
2024
Q4
$9.48K Sell
550
-11
-2% -$220 ﹤0.01% 1951
2024
Q3
$13.9K Sell
561
-29
-5% -$663 ﹤0.01% 2082
2024
Q2
$19.4K Buy
590
+40
+7% +$1.14K ﹤0.01% 1667
2024
Q1
$18.1K Sell
550
-80
-13% -$2.72K ﹤0.01% 1266
2023
Q4
$24K Hold
630
﹤0.01% 1203
2023
Q3
$24K Hold
630
﹤0.01% 1105
2023
Q2
$26K Sell
630
-47
-7% -$1.74K ﹤0.01% 935
2023
Q1
$23K Buy
677
+47
+7% +$1.96K ﹤0.01% 1314
2022
Q4
$17K Buy
630
+80
+15% +$2.8K ﹤0.01% 1338
2022
Q3
$16K Hold
550
﹤0.01% 1164
2022
Q2
$22K Buy
+550
New +$18.5K ﹤0.01% 917

Other funds holding ADNT

Blue Trust Inc's ADNT Position: Q2 2026 in Review

Blue Trust Inc reduced its Adient (ADNT) stake by 2.1% in Q2 2026, selling an estimated $256 and leaving 553 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1864.

Blue Trust Inc first reported a position in ADNT in Q2 2022 and has held it in 17 quarters since. The position peaked at $26K in Q2 2023. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Blue Trust Inc held 553 shares of Adient worth $10.2K as of Q2 2026.
  • Blue Trust Inc sold 12 Adient shares in Q2 2026, an estimated $256.
  • Adient made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1864 holding.
  • Blue Trust Inc first reported a position in Adient in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Adient position peaked at $26K in Q2 2023.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.